Seres Therapeutics Share Price Rise Over Past Month; Q2 Earnings Steady As You Go [Seeking Alpha]
Seres Therapeutics, Inc. (MCRB)
Last seres therapeutics, inc. earnings: 11/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.serestherapeutics.com
Company Research
Source: Seeking Alpha
Summary Understanding the reasons for share price appreciation in the biotech space can be a black art. Seres Therapeutics (NASDAQ: MCRB ) offers such a conundrum at the moment. I summarised recent clinical trial developments just last month , so readers are referred to this summary. In that article I noted it seemed that the share price was breaking through a $10 barrier and this recovery was sustained until last week. Here I look for evidence on which a share price recovery could be based (remembering that 12 months ago the share price crashed from $35.77 on July 28 to $10.94 the following day). Recent share price movements Two charts give a clear picture of the situation. Firstly, there is the 18 month chart for Seres. This shows the crash in late July 2016, followed by the share price moving in the range $8.99-$14.56. Secondly, the 3 month chart indicates a breakout, although this has not been smooth with a correction along the way. Th
Show less
Read more
Impact Snapshot
Event Time:
MCRB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MCRB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MCRB alerts
High impacting Seres Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
MCRB
News
- World $2.5 Bn Human Microbiome Market Trends, Forecasts and Competitive Analysis 2018-2023 and 2024-2030 [Yahoo! Finance]Yahoo! Finance
- Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesBusiness Wire
- Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024Business Wire
- Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT [Yahoo! Finance]Yahoo! Finance
MCRB
Earnings
- 5/8/24 - Beat
MCRB
Sec Filings
- 5/8/24 - Form 10-Q
- 5/8/24 - Form 8-K
- 5/7/24 - Form 8-K
- MCRB's page on the SEC website